Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -15.91% vs -4.52% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 1,133.33% vs -127.27% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "44.40",
          "val2": "52.80",
          "chgp": "-15.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.90",
          "val2": "12.60",
          "chgp": "-53.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.60",
          "val2": "2.10",
          "chgp": "-23.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.10",
          "val2": "-0.30",
          "chgp": "1,133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "133.30%",
          "val2": "27.20%",
          "chgp": "10.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -2.63% vs 77.96% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -67.12% vs 155.73% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.70",
          "val2": "216.40",
          "chgp": "-2.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "51.10",
          "val2": "52.30",
          "chgp": "-2.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.20",
          "val2": "5.70",
          "chgp": "26.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-0.60",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.20",
          "val2": "21.90",
          "chgp": "-67.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.00%",
          "val2": "139.80%",
          "chgp": "-7.38%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

44.40

52.80

-15.91%

Operating Profit (PBDIT) excl Other Income

5.90

12.60

-53.17%

Interest

1.60

2.10

-23.81%

Exceptional Items

0.00

0.00

Consolidate Net Profit

3.10

-0.30

1,133.33%

Operating Profit Margin (Excl OI)

133.30%

27.20%

10.61%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -15.91% vs -4.52% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 1,133.33% vs -127.27% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

210.70

216.40

-2.63%

Operating Profit (PBDIT) excl Other Income

51.10

52.30

-2.29%

Interest

7.20

5.70

26.32%

Exceptional Items

-0.80

-0.60

-33.33%

Consolidate Net Profit

7.20

21.90

-67.12%

Operating Profit Margin (Excl OI)

66.00%

139.80%

-7.38%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -2.63% vs 77.96% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -67.12% vs 155.73% in Dec 2024

All Annual Results